Medicare Part D plans’ coverage and cost-sharing for acute rescue and preventive inhalers for chronic obstructive pulmonary disease

Eitemau Tebyg

• Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans
  gan: Kazi, Dhruv S., et al.
  Cyhoeddwyd: (2017)
• Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D
  gan: DeJong, Colette, et al.
  Cyhoeddwyd: (2019)
• Coverage For High Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D
  gan: Yazdany, Jinoos, et al.
  Cyhoeddwyd: (2015)
• MEDICARE PART D—COST BURDEN OF INHALED DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
  gan: Tseng, C., et al.
  Cyhoeddwyd: (2017)
• Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D
  gan: DeJong, Colette, et al.
  Cyhoeddwyd: (2020)